Correlation Between Summit Therapeutics and RILIN

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and RILIN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and RILIN into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and RILIN 3625 12 JAN 52, you can compare the effects of market volatilities on Summit Therapeutics and RILIN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of RILIN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and RILIN.

Diversification Opportunities for Summit Therapeutics and RILIN

-0.14

Correlation Coefficient

Summit Therapeutics  RILIN

Good diversification

The 3 months correlation between Summit and RILIN is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and RILIN 3625 12 JAN 52 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RILIN 3625 12 and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with RILIN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RILIN 3625 12 has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and RILIN go up and down completely randomly.

Pair Corralation between Summit Therapeutics and RILIN

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to under-perform the RILIN. In addition to that, Summit Therapeutics is 4.95 times more volatile than RILIN 3625 12 JAN 52. It trades about -0.03 of its total potential returns per unit of risk. RILIN 3625 12 JAN 52 is currently generating about -0.15 per unit of volatility. If you would invest  7,571  in RILIN 3625 12 JAN 52 on September 21, 2024 and sell it today you would lose (416.00) from holding RILIN 3625 12 JAN 52 or give up 5.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	60.32%
Values	Daily Returns

Summit Therapeutics PLC  vs.  RILIN 3625 12 JAN 52

Summit Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

RILIN 3625 12

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RILIN 3625 12 JAN 52 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for RILIN 3625 12 JAN 52 investors.

Pair Trading with Summit Therapeutics and RILIN

The main advantage of trading using opposite Summit Therapeutics and RILIN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, RILIN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RILIN will offset losses from the drop in RILIN's long position.

The idea behind Summit Therapeutics PLC and RILIN 3625 12 JAN 52 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.